CMENASDAQFinancial Services

CME GROUP INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$305.89

-0.44%

Alpha Vantage · 11/6/2026

Industry: Financial Data & Stock ExchangesCategory: Domestic Common StockCurrency: USDNews: 2 recent

Analyze CME free

One-year price history

Adjusted daily closes · 252 observations · as of Nov 6, 2026

Historical data, not a forecast

1 month

+10.7%

3 months

+16.6%

6 months

+9.8%

1 year

+17.1%

Year to date

+15.9%

52-week range

$217.55 – $315.61

Fundamental snapshot

Latest reported period: Sep 30, 2026

Sharadar reported data

Market cap

$109.49B

P/E

24.9

P/B

4.1

P/S

15.7

Revenue

$6.97B

Net income

$4.4B

Diluted EPS

12.19

Gross margin

100.00%

Net margin

63.10%

Return on equity

16.20%

Total debt

$158.6B

Cash

$2.2B

Free cash flow

$4.33B

Latest eight reported quarters

Reported quarterly values, newest first

Period	Revenue	Net income	Gross margin	Net margin	Free cash flow
Sep 30, 2026	$1.74B	$1.04B	100.00%	59.70%	$1.07B
Jun 30, 2026	$1.71B	$1.04B	100.00%	61.10%	$923.5M
Mar 31, 2026	$1.88B	$1.15B	100.00%	61.40%	$1.24B
Dec 31, 2025	$1.65B	$1.17B	100.00%	70.80%	$1.1B
Sep 30, 2025	$1.54B	$896.6M	100.00%	58.30%	$949.7M
Jun 30, 2025	$1.69B	$1.01B	100.00%	59.80%	$1.04B
Mar 31, 2025	$1.64B	$944.2M	100.00%	57.50%	$1.1B
Dec 31, 2024	$1.53B	$863.7M	100.00%	56.60%	$991.7M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent CME news

All market news

Simply Wall St·Nov 6, 202662 signal

Cboe Global Markets (CBOE) Joins Lawsuit Over Single Stock Perpetuals Approval

Cboe Global Markets (CBOE) has joined a legal challenge against the CFTC's approval of single-stock perpetual derivatives in U.S. markets, citing concerns about investor protection and oversight. This move aligns Cboe with other market participants questioning the fit of these products within existing regulatory frameworks. The decision reflects Cboe's strategy to defend its established, regulation-friendly derivatives products rather than pursuing every new product regulators permit.

Original source

Stock Titan·Nov 2, 202652 signal

A proposed 10,079-share sale at CME Group (NASDAQ: CME) comes from officer Julie Winkler.

CME Group officer Julie Winkler has proposed selling 10,079 common shares, valued at approximately $3.08 million, with an anticipated sale date of November 2, 2026. This proposed sale was detailed in a Form 144 SEC filing. The filing also listed the aggregate market value of the proposed sale and various acquisition entries for the shares, including performance and restricted shares acquired over several years.

Original source